PML tumour suppression and beyond: Therapeutic implications

Cristina Gamell; Piotr Jan Paul; Ygal Haupt; Sue Haupt

Journal article

PML tumour suppression and beyond: Therapeutic implications

Cristina Gamell, Piotr Jan Paul, Ygal Haupt, Sue Haupt

FEBS Letters | WILEY | Published : 2014

DOI: 10.1016/j.febslet.2014.02.007

University of Melbourne Researchers

Susan Haupt Author Clinical Pathology

Ygal Haupt Author The Sir Peter MacCallum Department of Oncology

Related Projects (4)

Treatment Of B-Lymphoma By Targeting Protein Degradation

B-cell lymphoma is the most common type blood cancer diagnosed in Australia, and Australia's fifth most common cancer. Despite remarkable ad..

Regulation Of Cellular Senescence

Cancer is constantly being suppressed in our bodies by a process that stops damaged cells from growing: 'senescence'. The mechanism that tra..

New Role For The E3 Ligase E6ap In The Control Of Cell Motility And Invasion

Cell motility and invasion are fundamental process in normal cellular functions, however, when deregulated they can lead to metastatic cance..

A Novel Approach To Restoration Of Tumour Suppression In Lung Cancer

Loss of a tumour suppressor is a key event in every cancer, including lung cancer. Therefore restoration of the expression and/or activity o..

Grants

Awarded by NHMRC

Awarded by NHMRC Fellowship

Funding Acknowledgements

We apologize to those authors whose work was not directly cited, but rather cited thought reviews, due to space limitations. This work was supported by NHMRC project Grants (1026990, 1026988, 1049179, 1063389) and NHMRC Fellowship to Y.H. (9628426), by the VESKI award, and by the CASS Foundation.